Ja Morant’s Season Ends with Elbow Injury, Grizzlies Face Uncertain Future
MEMPHIS, Tenn. (AP) — The Memphis Grizzlies announced Tuesday night that guard Ja Morant will miss the remainder of the 2025-26 NBA season due to a UCL sprain in his left elbow. The team stated Morant received a platelet-rich plasma (PRP) injection to aid in the healing process, effectively ending a challenging season for the star point guard.
Morant, 26, appeared in 20 games this season, averaging 19 points per game. This marks another setback for the Grizzlies and their franchise player, who has faced both on-court and off-court challenges in recent years. The injury occurred during a game against the Portland Trail Blazers on March 4, 2026, though the full extent wasn’t immediately known until further evaluation.
The PRP injection is a common treatment for ligament and tendon injuries, aiming to accelerate healing by concentrating the body’s natural growth factors. While the procedure is often successful, it typically requires a significant recovery period, ruling Morant out for the rest of the current campaign. For those unfamiliar, PRP therapy involves drawing a sample of the patient’s own blood, processing it to concentrate the platelets, and then injecting it back into the injured area.
This season has been challenging for the Grizzlies, who entered the year with high expectations after a strong showing in the Western Conference playoffs the previous season. Morant’s absence further complicates their playoff aspirations. The team currently sits in a competitive position in the Western Conference standings, but will need to rely on other players to step up in his absence.
The Grizzlies will gaze to players like Desmond Bane and Jaren Jackson Jr. To carry a heavier load offensively. Bane has emerged as a consistent scoring threat, while Jackson Jr. Provides rim protection and versatility on both ends of the court. Yet, replacing Morant’s dynamic playmaking and scoring ability will be a significant challenge.
Morant’s injury history has become a concern for the Grizzlies and their fanbase. Prior to this latest setback, he had dealt with injuries to his ankle and shoulder in recent seasons. The team will undoubtedly focus on a comprehensive rehabilitation program to ensure his full recovery and prevent future injuries.
The timing of the injury is particularly unfortunate for Morant, who was beginning to find his rhythm after a period of adjustment following previous suspensions. He had shown flashes of his All-Star form, but consistency remained an issue. The team had hoped he would build momentum heading into the playoffs, but those plans have now been derailed.
The Grizzlies’ front office will now face difficult decisions regarding the team’s future. They will need to assess their roster and determine whether to make any trades or signings to bolster their chances of competing in the playoffs. The development of younger players will also be crucial as they navigate the remainder of the season without their star player.
Looking ahead, the Grizzlies’ focus will shift to preparing for the 2026-27 season. They will need to address their depth and find ways to improve their overall team chemistry. Morant’s return will be a significant boost, but the team must also develop a more sustainable system that isn’t solely reliant on his individual brilliance.
The NBA season continues with numerous compelling storylines unfolding across the league. However, the news of Ja Morant’s injury casts a shadow over the Grizzlies’ season and raises questions about their long-term prospects. The team will need to demonstrate resilience and determination as they navigate this challenging period.
The Grizzlies have not announced a specific timeline for Morant’s recovery, but it is expected to capture several months. Fans can stay updated on his progress through official team channels and NBA reports. The team’s next game is scheduled for [insert date and opponent here – needs verification], and it remains to be seen how they will perform without their star point guard.
This is a developing story. Check back for updates.
